Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 8, 2026 · Leadership change · Financial statements
Telomir Pharmaceuticals, Inc.
7
Leadership change
Jun 8, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 9.01 | Financial statements and exhibits |
Telomir Pharmaceuticals, Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
) 100 SE 2nd St , Suite 2000 , #1009 Miami , Florida 33131 (Address of Principal Executive Offices) Registrant’s telephone number, including area code: (786) 396-6723 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230. 425) ☐ Soliciting ma…
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Telomir Pharmaceuticals, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
